1. World Congress of Nephrology (WCN) 2013 Satellite Symposium “Kidney and Lipids”, June 5–7, 2013, Fukuoka, Japan

   Preface 04 April 2014 Pages: 179 - 179

2. The kidney and lipids: preface

   • Bertram Kasiske
   • Takao Saito

   Preface 05 April 2014 Pages: 180 - 184

   

3. Epidemiology of dyslipidemia in chronic kidney disease

   • Kunitoshi Iseki

   Review Article 11 January 2014 Pages: 185 - 188

   

4. Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency

   • Shuma Hirashio
   • Toshinori Ueno
   • Takao Masaki

   Review Article 31 October 2013 Pages: 189 - 193

   

5. Pathology of glomerular lipidosis

   • Hiroshi Sato
   • Nobuyuki Takahashi
   • Takao Saito

   Review Article 16 October 2013 Pages: 194 - 196

   

6. Genetic associations in diabetic nephropathy

   • Antien L. Mooyaart

   Review Article 16 October 2013 Pages: 197 - 200

   

7. Treatment and impact of dyslipidemia in diabetic nephropathy

   • Tadashi Toyama
   • Miho Shimizu
   • Takashi Wada

   Review Article 07 November 2013 Pages: 201 - 205

8. Abnormal lipoprotein metabolism in diabetic nephropathy

   • Tsutomu Hirano

   Review Article 17 October 2013 Pages: 206 - 209

   

9. Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy

   • Daisuke Koya
   • Munehiro Kitada
   • Keizo Kanasaki

   Review Article 14 November 2013 Pages: 210 - 213

   

10. Topics in lipoprotein glomerulopathy: an overview

    • Takao Saito
    • Akira Matsunaga
    • Hitoshi Nakashima

    Review Article 23 October 2013 Pages: 214 - 217

    

11. Lipoprotein glomerulopathy in China

    • Yuqing Chen

    Review Article 29 October 2013 Pages: 218 - 219

12. Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia

    • Akira Matsunaga
    • Takao Saito

    Review Article 26 February 2014 Pages: 220 - 224

    

13. A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy

    • Efstratios Stratikos
    • Angeliki Chroni

    Review Article 23 October 2013 Pages: 225 - 229

    

14. APOE polymorphism and diabetic nephropathy

    • Shin-ichi Araki

    Review Article 13 September 2013 Pages: 230 - 233

15. Causes and consequences of lipoprotein(a) abnormalities in kidney disease

    • Florian Kronenberg

    Review Article 16 October 2013 Pages: 234 - 237

    

16. The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease

    • Sethu M. Madhavan
    • John F. O’Toole

    Review Article 15 November 2013 Pages: 238 - 242

    

17. Lipoprotein metabolism and CKD: overview

    • Philip Barter

    Review Article 20 September 2013 Pages: 243 - 246

    

18. Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease

    • Kerry-Anne Rye

    Review Article 20 September 2013 Pages: 247 - 250

    

19. Chronic kidney disease induced dysfunction of high density lipoprotein

    • Suguru Yamamoto
    • Valentina Kon

    Review Article 10 September 2013 Pages: 251 - 254

    

20. The role of lipids and uremic toxins in cardiovascular disease in CKD

    • Ziad A. Massy

    Review Article 27 September 2013 Pages: 255 - 256

    

21. Serum lipids and prevention of atherosclerotic cardiovascular events in hemodialysis patients

    • Tetsuo Shoji

    Review Article 27 September 2013 Pages: 257 - 260

22. In vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease

    • Katsunori Ikewaki

    Review Article 16 October 2013 Pages: 261 - 264

    

23. Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease

    • Nosratola D. Vaziri

    Review Article 24 August 2013 Pages: 265 - 268

24. Fabry disease: experience of screening dialysis patients for Fabry disease

    • Eiji Kusano
    • Osamu Saito
    • Yasushi Asano

    Review Article 06 November 2013 Pages: 269 - 273

    

25. Results of the 4D study: ten years of follow-up?

    • Christoph Wanner
    • Kai-Renke Schmidt
    • Vera Krane

    Review Article 29 October 2013 Pages: 274 - 277

26. Statins in chronic kidney disease: what do meta-analyses tell us?

    • Ashish Upadhyay

    Review Article 25 October 2013 Pages: 278 - 281

27. Do statins play a role in renoprotection?

    • Masato Kasahara
    • Takahiko Nakagawa
    • Kenji Ueshima

    Review Article 10 January 2014 Pages: 282 - 285

    

28. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome

    • Eri Muso

    Review Article Open access 18 February 2014 Pages: 286 - 290

    

29. Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs

    • Vito M. Campese

    Review Article 18 February 2014 Pages: 291 - 295

30. The Asia Pacific Meeting for Vasculitis and ANCA Workshop 2012: surgical treatment for Takayasu’s arteritis

    • Tetsuro Miyata

    Review Article 22 November 2013 Pages: 296 - 300

    

31. History of Kawasaki disease

    • Tomisaku Kawasaki
    • Shiro Naoe

    Review Article 06 March 2014 Pages: 301 - 304

    

32. Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency

    • Miho Shimizu
    • Kengo Furuichi
    • Takashi Wada

    Review Article 01 October 2013 Pages: 305 - 312

    

33. Knee extensor muscle strength and index of renal function associated with an exercise capacity of 5 metabolic equivalents in male chronic heart failure patients with chronic kidney disease

    • Chiharu Hotta
    • Koji Hiraki
    • Kenjiro Kimura

    Original Article 26 June 2013 Pages: 313 - 319

    

34. Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy

    • Daigo Kamei
    • Takahito Moriyama
    • Kosaku Nitta

    Original Article 07 June 2013 Pages: 320 - 328

    

35. Characteristics and 3-year mortality and infection rates among incident hemodialysis patients with a permanent catheter undergoing a first vascular access conversion

    • Yee-Yung Ng
    • Yen-Ni Hung
    • Po-Jen Ko

    Original Article 12 June 2013 Pages: 329 - 338